沃华医药(002107.SZ)将变为无实控人状态

Core Viewpoint - The Beijing Third Intermediate People's Court has upheld a second-instance ruling regarding the property dispute between Zhao Bingxian and Lu Juan, resulting in an equal division of their shares in Zhongzheng Wanrong Investment Group, which is the controlling shareholder of WoHua Pharmaceutical [1] Group 1: Legal Proceedings - The court's ruling maintains the first-instance decision from the Tongzhou District People's Court, confirming that Zhao Bingxian and Lu Juan will each hold 50% of Zhongzheng Wanrong Investment Group's shares [1] - The ruling specifically pertains to the division of shares held by Zhao Bingxian and Lu Juan and does not affect Zhongzheng Wanrong Investment Group's 50.27% stake in WoHua Pharmaceutical [1] Group 2: Impact on Company Control - The outcome of the court ruling results in a change in the actual controller of WoHua Pharmaceutical, shifting from Zhao Bingxian to a state of no actual controller [1]